A pharmacist-led collaborative drug therapy management program at NYC Health + Hospitals/Bellevue reported high patient satisfaction, and every surveyed patient said they felt respected and supported by their pharmacist.
|Articles|October 14, 2021
Pharmacy Clinical Pearl of the Day: Actinic Keratosis
Author(s)Saro Arakelians, PharmD
Actinic keratosis develops from years of sun exposure and usually first appears in people over 40 years of age.
Advertisement
Clinical Pearl of the Day: Actinic Keratosis
Actinic keratosis is a rough, scaly patch on the skin that develops from years of sun exposure.
Insight:
- Also known as a solar keratosis, actinic keratosis grows slowly and usually first appears in people over 40 years of age.
- The impact can be reduced by minimizing sun exposure and protecting the skin from ultraviolet rays.
- Symptoms include rough, dry, or scaly patches of skin, usually less than 1 inch in diameter; flat to slightly raised patches or bumps; a hard, wart-like surface; color variations, including pink, red, or brown skin; itching, burning, bleeding, and crusting on the skin.
- Treatment includes medicated cream or gel to remove the impacted skin, such as fluorouracil, imiquimod, or diclofenac. There are other methods also used, including freezing (cryotherapy), scraping (curettage), laser therapy, or photodynamic therapy.
- Sources:
Actinic keratosis - Symptoms and causes - Mayo Clinic actinic keratosis image - Google Search
Advertisement
Related to this article
A Novo Nordisk-funded claims analysis of adults with type 2 diabetes found an adjusted HR of 1.06 for MACE with switching, though the findings cannot show causation.
Invasive pneumococcal disease may be the first sign of undiagnosed blood cancers and antibody deficiencies in adults, a new study finds.
A new analysis finds a significant weight loss edge for tirzepatide under one estimand but not another; no head-to-head trial exists at these doses.
In SCOUT-HCM, mavacamten reduced the Valsalva LVOT gradient by 48 mm Hg versus placebo in adolescents. REMS, echo monitoring, and CYP interactions still apply in the new population.
Indirect comparison links orforglipron 17.2 mg to 1.5% more weight loss and 0.3% more A1C lowering than oral semaglutide 25 mg in adults with type 2 diabetes.
Pharmacists can help overcome influenza vaccine hesitancy by correcting common misconceptions, routinely asking every patient about vaccination, and leveraging their standing as trusted health care professionals.
Phase 3 TRIUMPH-2 data presented at EASD show HbA1C reductions up to 1.6%, with GI effects, hypotension, and dysesthesia as key counseling points.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tirzepatide Linked to More Weight Loss Than Semaglutide 7.2 mg
2
Pharmacist, Advocate, Ally: Delivering Comprehensive Gender-Affirming Care
3
September 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
4
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
5